232 related articles for article (PubMed ID: 23153384)
61. Reported sexual abuse predicts impaired functioning but a good response to psychological treatments in patients with severe irritable bowel syndrome.
Creed F; Guthrie E; Ratcliffe J; Fernandes L; Rigby C; Tomenson B; Read N; Thompson DG
Psychosom Med; 2005; 67(3):490-9. PubMed ID: 15911915
[TBL] [Abstract][Full Text] [Related]
62. Gastrointestinal-specific anxiety: an important factor for severity of GI symptoms and quality of life in IBS.
Jerndal P; Ringström G; Agerforz P; Karpefors M; Akkermans LM; Bayati A; Simrén M
Neurogastroenterol Motil; 2010 Jun; 22(6):646-e179. PubMed ID: 20367800
[TBL] [Abstract][Full Text] [Related]
63. The structure of resilience in irritable bowel syndrome and its improvement through hypnotherapy: Cross-sectional and prospective longitudinal data.
Peter J; Tran US; Michalski M; Moser G
PLoS One; 2018; 13(11):e0202538. PubMed ID: 30419026
[TBL] [Abstract][Full Text] [Related]
64. Reports of "satisfactory relief" by IBS patients receiving usual medical care are confounded by baseline symptom severity and do not accurately reflect symptom improvement.
Whitehead WE; Palsson OS; Levy RL; Feld AD; VonKorff M; Turner M
Am J Gastroenterol; 2006 May; 101(5):1057-65. PubMed ID: 16573774
[TBL] [Abstract][Full Text] [Related]
65. A randomized controlled trial of cognitive behavior therapy, relaxation training, and routine clinical care for the irritable bowel syndrome.
Boyce PM; Talley NJ; Balaam B; Koloski NA; Truman G
Am J Gastroenterol; 2003 Oct; 98(10):2209-18. PubMed ID: 14572570
[TBL] [Abstract][Full Text] [Related]
66. [Psychotherapy in somatic diseases--for example gastrointestinal disorders].
Moser G
Psychiatr Danub; 2007 Dec; 19(4):327-31. PubMed ID: 18000484
[TBL] [Abstract][Full Text] [Related]
67. Review article: The history of hypnotherapy and its role in the irritable bowel syndrome.
Whorwell PJ
Aliment Pharmacol Ther; 2005 Dec; 22(11-12):1061-7. PubMed ID: 16305719
[TBL] [Abstract][Full Text] [Related]
68. Self-reported food-related gastrointestinal symptoms in IBS are common and associated with more severe symptoms and reduced quality of life.
Böhn L; Störsrud S; Törnblom H; Bengtsson U; Simrén M
Am J Gastroenterol; 2013 May; 108(5):634-41. PubMed ID: 23644955
[TBL] [Abstract][Full Text] [Related]
69. Where does hypnotherapy stand in the management of irritable bowel syndrome? A systematic review.
Gholamrezaei A; Ardestani SK; Emami MH
J Altern Complement Med; 2006; 12(6):517-27. PubMed ID: 16884342
[TBL] [Abstract][Full Text] [Related]
70. Randomised clinical trial: symptoms of the irritable bowel syndrome are improved by a psycho-education group intervention.
Labus J; Gupta A; Gill HK; Posserud I; Mayer M; Raeen H; Bolus R; Simren M; Naliboff BD; Mayer EA
Aliment Pharmacol Ther; 2013 Feb; 37(3):304-15. PubMed ID: 23205588
[TBL] [Abstract][Full Text] [Related]
71. Internet-delivered exposure and mindfulness based therapy for irritable bowel syndrome--a randomized controlled trial.
Ljótsson B; Falk L; Vesterlund AW; Hedman E; Lindfors P; Rück C; Hursti T; Andréewitch S; Jansson L; Lindefors N; Andersson G
Behav Res Ther; 2010 Jun; 48(6):531-9. PubMed ID: 20362976
[TBL] [Abstract][Full Text] [Related]
72. Determinants of quality of life in irritable bowel syndrome.
Rey E; García-Alonso MO; Moreno-Ortega M; Alvarez-Sanchez A; Diaz-Rubio M
J Clin Gastroenterol; 2008 Oct; 42(9):1003-9. PubMed ID: 18719505
[TBL] [Abstract][Full Text] [Related]
73. Effects of a proprietary Bacillus coagulans preparation on symptoms of diarrhea-predominant irritable bowel syndrome.
Dolin BJ
Methods Find Exp Clin Pharmacol; 2009 Dec; 31(10):655-9. PubMed ID: 20140275
[TBL] [Abstract][Full Text] [Related]
74. Symptom severity but not psychopathology predicts visceral hypersensitivity in irritable bowel syndrome.
van der Veek PP; Van Rood YR; Masclee AA
Clin Gastroenterol Hepatol; 2008 Mar; 6(3):321-8. PubMed ID: 18258487
[TBL] [Abstract][Full Text] [Related]
75. Systematic review: the effectiveness of hypnotherapy in the management of irritable bowel syndrome.
Wilson S; Maddison T; Roberts L; Greenfield S; Singh S;
Aliment Pharmacol Ther; 2006 Sep; 24(5):769-80. PubMed ID: 16918880
[TBL] [Abstract][Full Text] [Related]
76. Smartphone app-delivered gut-directed hypnotherapy improves symptoms of self-reported irritable bowel syndrome: A retrospective evaluation.
Peters SL; Gibson PR; Halmos EP
Neurogastroenterol Motil; 2023 Apr; 35(4):e14533. PubMed ID: 36661117
[TBL] [Abstract][Full Text] [Related]
77. Irritable bowel syndrome: an international study of symptoms in eight countries.
Gerson CD; Gerson MJ; Awad RA; Chowdhury A; Dancey C; Poitras P; Porcelli P; Sperber A; Wang WA
Eur J Gastroenterol Hepatol; 2008 Jul; 20(7):659-67. PubMed ID: 18679069
[TBL] [Abstract][Full Text] [Related]
78. [Irritable bowel syndrome: outcome aspects].
Bruley des Varannes S
Gastroenterol Clin Biol; 2009 Feb; 33 Suppl 1():S84-90. PubMed ID: 19303543
[TBL] [Abstract][Full Text] [Related]
79. Eluxadoline benefits patients with irritable bowel syndrome with diarrhea in a phase 2 study.
Dove LS; Lembo A; Randall CW; Fogel R; Andrae D; Davenport JM; McIntyre G; Almenoff JS; Covington PS
Gastroenterology; 2013 Aug; 145(2):329-38.e1. PubMed ID: 23583433
[TBL] [Abstract][Full Text] [Related]
80. Complementary and alternative medicine for IBS in adults: mind-body interventions.
Kearney DJ; Brown-Chang J
Nat Clin Pract Gastroenterol Hepatol; 2008 Nov; 5(11):624-36. PubMed ID: 18825145
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
